Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,581 shares at $94.96 ($150K) on 2021-06-21, disclosed to the SEC on 2021-06-23.
Open-market sale of $150k RARE by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.63 | 437 | $41K | 27.6% |
| 2 | $94.96 | 572 | $54K | 36.2% |
| 3 | $94.96 | 572 | $54K | 36.2% |
| Total | $94.87 avg | 1,581 | $150K | 100% |
| Filing → |
| RARE | SELL | 2024-03-05 | $513K | — | Filing → |
| RARE | SELL | 2023-09-06 | $228K | — | Filing → |
| RARE | SELL | 2023-06-21 | $15K | — | Filing → |